Maddalena Centanni
Forskare vid Institutionen för farmaci; Farmakokinetik och Farmakodynamik
- E-post:
- maddalena.centanni@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Publikationer
Senaste publikationer
-
Ingår i CPT, 2026
- DOI för Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias
- Ladda ner fulltext (pdf) av Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias
-
Ingår i Clinical Pharmacology and Therapeutics, s. 403-413, 2026
- DOI för Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer
- Ladda ner fulltext (pdf) av Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer
-
Ingår i British Journal of Haematology, s. 1920-1929, 2025
- DOI för Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study
- Ladda ner fulltext (pdf) av Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study
-
Ingår i PharmacoEconomics (Auckland), s. 1433-1449, 2025
- DOI för Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing Regimens
- Ladda ner fulltext (pdf) av Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing Regimens
-
Ingår i PharmacoEconomics (Auckland), s. 31-43, 2025
- DOI för Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy
- Ladda ner fulltext (pdf) av Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy
Alla publikationer
Artiklar i tidskrift
-
Ingår i CPT, 2026
- DOI för Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias
- Ladda ner fulltext (pdf) av Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias
-
Ingår i Clinical Pharmacology and Therapeutics, s. 403-413, 2026
- DOI för Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer
- Ladda ner fulltext (pdf) av Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer
-
Ingår i British Journal of Haematology, s. 1920-1929, 2025
- DOI för Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study
- Ladda ner fulltext (pdf) av Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study
-
Ingår i PharmacoEconomics (Auckland), s. 1433-1449, 2025
- DOI för Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing Regimens
- Ladda ner fulltext (pdf) av Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing Regimens
-
Ingår i PharmacoEconomics (Auckland), s. 31-43, 2025
- DOI för Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy
- Ladda ner fulltext (pdf) av Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy
-
Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
Ingår i Advanced Drug Delivery Reviews, 2025
- DOI för Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
- Ladda ner fulltext (pdf) av Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
-
Ingår i Leukemia, s. 712-719, 2024
- DOI för Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
- Ladda ner fulltext (pdf) av Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
-
Pharmacogenetic testing or Therapeutic Drug Monitoring: A Quantitative Framework
Ingår i Clinical Pharmacokinetics, s. 871-884, 2024
- DOI för Pharmacogenetic testing or Therapeutic Drug Monitoring: A Quantitative Framework
- Ladda ner fulltext (pdf) av Pharmacogenetic testing or Therapeutic Drug Monitoring: A Quantitative Framework
-
Ingår i Cancer Chemotherapy and Pharmacology, s. 297-310, 2024
- DOI för Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children
- Ladda ner fulltext (pdf) av Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children
-
Ingår i Clinical Pharmacokinetics, s. 197-209, 2024
- DOI för Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
- Ladda ner fulltext (pdf) av Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
-
Ingår i Clinical and Translational Science, s. 73-84, 2023
- DOI för Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine-kinase inhibitors
- Ladda ner fulltext (pdf) av Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine-kinase inhibitors
-
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors
Ingår i Clinical Cancer Research, s. 4590-4598, 2020
-
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
Ingår i Frontiers in Pharmacology, 2020
- DOI för Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
- Ladda ner fulltext (pdf) av Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
Artiklar, forskningsöversikt
-
Model-informed precision dosing: State of the art and future perspectives
Ingår i Advanced Drug Delivery Reviews, 2024
- DOI för Model-informed precision dosing: State of the art and future perspectives
- Ladda ner fulltext (pdf) av Model-informed precision dosing: State of the art and future perspectives